Preparation, characterization, cytotoxicity and pharmacokinetics of niosomes containing gemcitabine: In vitro, in vivo, and simulation studies

[1]  Kui Luo,et al.  Artificial Intelligence Aids in Development of Nanomedicines for Cancer Management. , 2023, Seminars in cancer biology.

[2]  Pourya Mohammadi,et al.  An intelligent DNA nanorobot for detection of MiRNAs cancer biomarkers using molecular programming to fabricate a logic-responsive hybrid nanostructure , 2022, Bioprocess and Biosystems Engineering.

[3]  Hongyan Zhu,et al.  A tumor cell membrane-coated self-amplified nanosystem as a nanovaccine to boost the therapeutic effect of anti-PD-L1 antibody , 2022, Bioactive materials.

[4]  H. Azzazy,et al.  Ozonated Olive Oil: Enhanced Cutaneous Delivery via Niosomal Nanovesicles for Melanoma Treatment , 2022, Antioxidants.

[5]  R. Sheervalilou,et al.  Effects of folate-conjugated Fe2O3@Au core–shell nanoparticles on oxidative stress markers, DNA damage, and histopathological characteristics: evidence from in vitro and in vivo studies , 2022, Medical Oncology.

[6]  Jinming Zhang,et al.  Oral colon-targeted mucoadhesive micelles with enzyme-responsive controlled release of curcumin for ulcerative colitis therapy , 2022, Chinese Chemical Letters.

[7]  H. Karimi-Maleh,et al.  Fe3O4@Au-rGO Nanocomposite/Ionic Liquid Modified Sensor for Ultrasensitive and Selective Sensing of Doxorubicin , 2022, Topics in Catalysis.

[8]  A. Jemal,et al.  Cancer statistics, 2022 , 2022, CA: a cancer journal for clinicians.

[9]  S. Pandey,et al.  Nanotechnology-based approaches for effective detection of tumor markers: A comprehensive state-of-the-art review. , 2021, International journal of biological macromolecules.

[10]  Kinam Park,et al.  Evolution of drug delivery systems: From 1950 to 2020 and beyond. , 2021, Journal of controlled release : official journal of the Controlled Release Society.

[11]  F. Baino,et al.  In vitro and in vivo anticancer effect of pH-responsive paclitaxel-loaded niosomes , 2021, Journal of Materials Science: Materials in Medicine.

[12]  S. Pandey,et al.  Simulation, In Vitro, and In Vivo Cytotoxicity Assessments of Methotrexate-Loaded pH-Responsive Nanocarriers , 2021, Polymers.

[13]  M. Bilal,et al.  Pluronic F127/Doxorubicin microemulsions: Preparation, characterization, and toxicity evaluations , 2021, Journal of Molecular Liquids.

[14]  Milad Shirvaliloo,et al.  An Updated Review on Implications of Autophagy and Apoptosis in Tumorigenesis: Possible Alterations in Autophagy through Engineered Nanomaterials and Their Importance in Cancer Therapy , 2021, Molecular Pharmacology.

[15]  R. Sheervalilou,et al.  Magnetic Hyperthermia as an adjuvant cancer therapy in combination with radiotherapy versus radiotherapy alone for recurrent/progressive glioblastoma: a systematic review , 2021, Journal of Neuro-Oncology.

[16]  Moganavelli Singh,et al.  Recent Advances in Lipid-Based Nanosystems for Gemcitabine and Gemcitabine–Combination Therapy , 2021, Nanomaterials.

[17]  C. Mai,et al.  Co-encapsulation of gemcitabine and tocotrienols in nanovesicles enhanced efficacy in pancreatic cancer. , 2021, Nanomedicine.

[18]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[19]  M. B. Abdul Rahman,et al.  Aerosolized Niosome Formulation Containing Gemcitabine and Cisplatin for Lung Cancer Treatment: Optimization, Characterization and In Vitro Evaluation , 2021, Pharmaceutics.

[20]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[21]  Benjamin A. Shoemaker,et al.  PubChem in 2021: new data content and improved web interfaces , 2020, Nucleic Acids Res..

[22]  M. Metwally,et al.  Nanotechnology improves the therapeutic efficacy of gemcitabine against a human hepatocellular carcinoma cell line and minimizes its in vivo side effects , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.

[23]  L. Marelli,et al.  A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System , 2020, Case reports in hepatology.

[24]  Kui Luo,et al.  Recent advances in development of dendriticpolymer-based nanomedicines for cancer diagnosis. , 2020, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[25]  C. Garrido,et al.  Dual inhibitors of Histone Deacetylases and Other Cancer-Related Targets: A Pharmacological Perspective. , 2020, Biochemical pharmacology.

[26]  Purnima Tripathi,et al.  Niosomes: A review on niosomal research in the last decade , 2020 .

[27]  A. Borowsky,et al.  Tumor-specific delivery of gemcitabine with activatable liposomes. , 2019, Journal of controlled release : official journal of the Controlled Release Society.

[28]  Z. Rezaei,et al.  Induction of apoptosis and modulation of homologous recombination DNA repair pathway in prostate cancer cells by the combination of AZD2461 and valproic acid , 2019, EXCLI journal.

[29]  R. Saravani,et al.  Mild antagonistic effect of Valproic acid in combination with AZD2461 in MCF-7 breast cancer cells , 2019, Medical journal of the Islamic Republic of Iran.

[30]  V. Bakshi,et al.  Niosomes: A Novel Trend in Drug Delivery , 2018 .

[31]  Yanli Zhao,et al.  Independent of EPR Effect: A Smart Delivery Nanosystem for Tracking and Treatment of Nonvascularized Intra‐Abdominal Metastases , 2018, Advanced Functional Materials.

[32]  Yuan-quan Yu,et al.  Gemcitabine induces apoptosis and autophagy via the AMPK/mTOR signaling pathway in pancreatic cancer cells , 2018, Biotechnology and applied biochemistry.

[33]  J. Jassem,et al.  Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation. , 2017, Oncology letters.

[34]  A. Pardakhty,et al.  Changes in physical and chemical properties of niosome membrane induced by cholesterol: a promising approach for niosome bilayer intervention , 2017 .

[35]  M. I. Khan,et al.  Development and in-vitro characterization of sorbitan monolaurate and poloxamer 184 based niosomes for oral delivery of diacerein. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[36]  R. Pomès,et al.  Sampling errors in free energy simulations of small molecules in lipid bilayers. , 2016, Biochimica et biophysica acta.

[37]  H. Hatcher,et al.  Anticancer chemotherapy in teenagers and young adults: managing long term side effects , 2016, British Medical Journal.

[38]  K. Kuczera,et al.  Permeation of the three aromatic dipeptides through lipid bilayers: Experimental and computational study. , 2016, The Journal of chemical physics.

[39]  A. Grigorian,et al.  Hepatotoxicity Secondary to Chemotherapy , 2014, Journal of clinical and translational hepatology.

[40]  R. Alany,et al.  Recent advances in non-ionic surfactant vesicles (niosomes): self-assembly, fabrication, characterization, drug delivery applications and limitations , 2014, Drug delivery.

[41]  Benjamin D. Madej,et al.  Lipid14: The Amber Lipid Force Field , 2014, Journal of chemical theory and computation.

[42]  S. Chime,et al.  Lipid-based drug delivery systems (LDDS): Recent advances and applications of lipids in drug delivery , 2013 .

[43]  Massimiliano Bonomi,et al.  PLUMED 2: New feathers for an old bird , 2013, Comput. Phys. Commun..

[44]  A. Demchenko.  Beyond annexin V: fluorescence response of cellular membranes to apoptosis , 2013, Cytotechnology.

[45]  J. Kopeček,et al.  Biological rationale for the design of polymeric anti-cancer nanomedicines , 2013, Journal of drug targeting.

[46]  A. Richetta,et al.  Gemcitabine-Induced Extensive Skin Necrosis , 2012, Case reports in medicine.

[47]  H. Car,et al.  Nanoparticles as drug delivery systems , 2012, Pharmacological reports : PR.

[48]  R. Elber,et al.  Unassisted transport of N-acetyl-L-tryptophanamide through membrane: experiment and simulation of kinetics. , 2012, The journal of physical chemistry. B.

[49]  Karel Berka,et al.  Convergence of Free Energy Profile of Coumarin in Lipid Bilayer , 2012, Journal of chemical theory and computation.

[50]  G. P. Kumar,et al.  Nonionic surfactant vesicular systems for effective drug delivery—an overview , 2011 .

[51]  W F Drew Bennett,et al.  Statistical Convergence of Equilibrium Properties in Simulations of Molecular Solutes Embedded in Lipid Bilayers. , 2011, Journal of chemical theory and computation.

[52]  Piotr Cieplak,et al.  R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments , 2011, Nucleic Acids Res..

[53]  Jens Krüger,et al.  CELLmicrocosmos 2.2 MembraneEditor: A Modular Interactive Shape-Based Software Approach To Solve Heterogeneous Membrane Packing Problems , 2011, J. Chem. Inf. Model..

[54]  A. Holstein,et al.  Gemcitabine induced digital ischaemia and necrosis. , 2010, European journal of cancer care.

[55]  P. Hall,et al.  Toxicities of Gemcitabine in Patients with Severe Hepatic Dysfunction , 2010, The Annals of pharmacotherapy.

[56]  Jonathan W Essex,et al.  Permeability of small molecules through a lipid bilayer: a multiscale simulation study. , 2009, The journal of physical chemistry. B.

[57]  S. Mirzaei,et al.  Determination of the Toxicity Effect of Sorbitan Esters Surfactants Group on Biological Membrane , 2009 .

[58]  A. Sood,et al.  Nuclear Factor-κB p65/relA Silencing Induces Apoptosis and Increases Gemcitabine Effectiveness in a Subset of Pancreatic Cancer Cells , 2008, Clinical Cancer Research.

[59]  In-Young Kim,et al.  Preparation of pH-sensitive, long-circulating and EGFR-targeted immunoliposomes , 2008, Archives of pharmacal research.

[60]  S. Nie,et al.  Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .

[61]  B. Li,et al.  Inducing apoptosis and enhancing chemosensitivity to Gemcitabine via RNA interference targeting Mcl-1 gene in pancreatic carcinoma cell , 2008, Cancer Chemotherapy and Pharmacology.

[62]  E. Mini,et al.  Cellular pharmacology of gemcitabine. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[63]  B. Nasseri.  Effect of cholesterol and temperature on the elastic properties of niosomal membranes. , 2005, International journal of pharmaceutics.

[64]  V. Labhasetwar,et al.  Targeted Drug Delivery in Cancer Therapy , 2005, Technology in cancer research & treatment.

[65]  R. Esenaliev,et al.  Enhancement of Drug Delivery in Tumors by Using Interaction of Nanoparticles with Ultrasound Radiation , 2005, Technology in cancer research & treatment.

[66]  David R. Jones,et al.  Proteasome inhibition sensitizes non-small-cell lung cancer to gemcitabine-induced apoptosis. , 2004, The Annals of thoracic surgery.

[67]  Gabriel A Silva,et al.  Introduction to nanotechnology and its applications to medicine. , 2004, Surgical neurology.

[68]  A. Noreddin,et al.  Effects of gemcitabine on cisplatin-induced nephrotoxicity in rats: schedule-dependent study. , 2001, Pharmacological research.

[69]  G. Peters,et al.  Chemotherapy triggers apoptosis in a caspase-8-dependent and mitochondria-controlled manner in the non-small cell lung cancer cell line NCI-H460. , 2000, Cancer research.

[70]  M. Tsao,et al.  Inhibition of phosphatidylinositide 3-kinase enhances gemcitabine-induced apoptosis in human pancreatic cancer cells. , 2000, Cancer research.

[71]  L. Mayer,et al.  Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[72]  J. Nagle,et al.  Analysis of simulated NMR order parameters for lipid bilayer structure determination. , 1999, Biophysical journal.

[73]  W. Konings,et al.  The ABC family of multidrug transporters in microorganisms. , 1998, Biochimica et biophysica acta.

[74]  D. van der Spoel,et al.  GROMACS: A message-passing parallel molecular dynamics implementation , 1995 .

[75]  Herman J. C. Berendsen,et al.  Simulation of Water Transport through a Lipid Membrane , 1994 .

[76]  R. Swendsen,et al.  THE weighted histogram analysis method for free‐energy calculations on biomolecules. I. The method , 1992 .

[77]  H. Junginger,et al.  Safety Aspects of Non‐ionic Surfactant Vesicles: A Toxicity Study Related to the Physicochemical Characteristics of Non‐ionic Surfactants , 1992, The Journal of pharmacy and pharmacology.

[78]  András Baranyai,et al.  New algorithm for constrained molecular-dynamics simulation of liquid benzene and naphthalene , 1990 .

[79]  M. Luscombe,et al.  A study of some variables in a tetrazolium dye (MTT) based assay for cell growth and chemosensitivity. , 1987, British Journal of Cancer.

[80]  R K Jain,et al.  Transport of molecules in the tumor interstitium: a review. , 1987, Cancer research.

[81]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[82]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[83]  A. Guddati,et al.  Management of hepatotoxicity of chemotherapy and targeted agents. , 2021, American journal of cancer research.

[84]  H. Hansen,et al.  Clinical and preclinical activity of 2',2'-difluorodeoxycytidine (gemcitabine). , 1993, Cancer treatment reviews.

[85]  D. Fink.  Cancer overview. , 1979, Cancer research.